Viruses, Vol. 11, Pages 365: Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells
Viruses, Vol. 11, Pages 365: Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells
Viruses doi: 10.3390/v11040365
Authors:
Jean A. Bernatchez
Michael Coste
Sungjun Beck
Grace A. Wells
Lucas A. Luna
Alex E. Clark
Zhe Zhu
David Hecht
Jeremy N. Rich
Christal D. Sohl
Byron W. Purse
Jair L. Siqueira-Neto
Zika virus (ZIKV), an emerging flavivirus that causes neurodevelopmental impairment to fetuses and has been linked to Guillain-Barré syndrome continues to threaten global health due to the absence of targeted prophylaxis or treatment. Nucleoside analogues are good examples of efficient anti-viral inhibitors, and prodrug strategies using phosphate masking groups (ProTides) have been employed to improve the bioavailability of ribonucleoside analogues. Here, we synthesized and tested a small library of 13 ProTides against ZIKV in human neural stem cells. Strong activity was observed for 2′-C-methyluridine and 2′-C-ethynyluridine ProTides with an aryloxyl phosphoramidate masking group. Substitution of a 2-(methylthio) ethyl phosphoramidate for the aryloxyl phosphoramidate ProTide group of 2′-C-methyluridine completely abolished antiviral activity of the compound. The aryloxyl phosphoramidate ProTide of 2′-C-methyluridine outperformed the hepatitis C virus (HCV) drug sofosbuvir in suppression of viral titers and protection from cytopathic effect...
Source: Viruses - Category: Virology Authors: Jean A. Bernatchez Michael Coste Sungjun Beck Grace A. Wells Lucas A. Luna Alex E. Clark Zhe Zhu David Hecht Jeremy N. Rich Christal D. Sohl Byron W. Purse Jair L. Siqueira-Neto Tags: Article Source Type: research
More News: Brain | Databases & Libraries | Guillain-Barr Syndrome | Hepatitis | Hepatitis C | Neurology | Stem Cell Therapy | Stem Cells | Virology | Zika Virus